Changes in monoamine metabolism in the brain during unilateral cortical spreading depression in BALB/c mice

Abstract

BACKGROUND: BALB/c mice can be adequate models for elucidating the actions of neurotropic drugs in conditions of abnormal interhemispheric interactions.

AIM: To examine the effect of unilateral cortical spreading depression on monoamine metabolism in BALB/c mice.

MATERIALS AND METHODS: Twenty-four adult male BALB/c mice were analyzed. Unilateral cortical spreading depression (functional inactivation of one of the cerebral hemisphere cortex) was induced by applying a 1 × 1 mm filter paper moistened with a 25% KCl solution. Fifteen minutes after exposure, the animals were decapitated. By using high-performance liquid chromatography with an electrochemical detector in the cerebral cortex, hippocampus, olfactory tubercle, and striatum, the levels of norepinephrine (NE), dopamine (DA), serotonin (5-HT) and their metabolites (dioxyphenylacetic [DOPAC], homovanilinic [HVA] and 5-hydroxyindolacetic acids) were measured.

RESULTS: Unilateral cortical spreading depression was accompanied by a decrease in NE levels in the hippocampus and an increase in the DA extracellular metabolism (HVA and/or HVA/DA) in the olfactory tubercle and striatum on the side of the inactivated cortex. In addition to the listed effects, only functional inactivation of the right hemisphere caused a bilateral decrease in the NE level in the cortex and a decrease in the NE level and the DOPAC/DA ratio in the left (contralateral) hippocampus. No regular changes were noted in the posture of animals after the unilateral inactivation of the cerebral cortex.

CONCLUSION:The results suggest that in BALB/c mice, the right hemisphere cortex plays a dominant role in regulating the activity of the noradrenergic system in the brain.

Keywords

BALB/c mice / autism model / cortical spreading depression / monoamines / brain asymmetry

References

[1] Shaposhnikova AF. Medikamentoznoe lechenie pri detskom autizme. Autism and Developmental Disorders. 2008;6(3):43–48. (In Russ. )

[2] Шапошникова А. Ф. Медикаментозное лечение при детском аутизме // Аутизм и нарушения развития. 2008. Т. 6, № 3. С. 43–48.

[3] Lavrov NV, Shabanov PD. Autism spectrum disorders: etiology, treatment. models and experimental studies. Reviews on Clinical Pharmacology and Drug Therapy. 2018;16(1):21–27. (In Russ. ) DOI: 10. 17816/RCF16121-27

[4] Лавров Н. В., Шабанов П. Д. Расстройства аутистического спектра: этиология, лечение, экспериментальные подходы к моделированию // Обзоры по клинической фармакологии и лекарственной терапии. 2018. Т. 16, № 1. С. 21–27. DOI: 10. 17816/RCF16121-27

[5] Casanova MF, El-Baz A, Elnakib A, et al. Quantitative analysis of the shape of the corpus callosum in autistic individuals. Autism. 2011;15(2):223–238. DOI: 10. 1177/1362361310386506

[6] Casanova M. F., El-Baz A., Elnakib A., et al. Quantitative analysis of the shape of the corpus callosum in autistic individuals // Autism. 2011. Vol. 15, No. 2. P. 223–238. DOI: 10. 1177/1362361310386506

[7] Hardana AY, Pabalanb M, Guptaa N, et al. Corpus callosum volume in children with autism. Psychiatry Res. 2009;174(1):57–61. DOI: 10. 1016/j. pscychresns. 2009. 03. 005

[8] Hardana A. Y., Pabalanb M., Guptaa N., et al. Corpus callosum volume in children with autism // Psychiatry Res. 2009. Vol. 174, No. 1. P. 57–61. DOI: 10. 1016/j. pscychresns. 2009. 03. 005

[9] Floris DL, Wolfers T, Zabihi M, et al. Atypical brain asymmetry in autism – a candidate for clinically meaningful stratification. Biol Psychiatry: Cogn Neurosci Neuroimaging. 2021;6(8):802–812. DOI: 10. 1016/j. bpsc. 2020. 08. 008

[10] Floris D. L., Wolfers T., Zabihi M., et al. Atypical brain asymmetry in autism – a candidate for clinically meaningful stratification // Biol Psychiatry: Cogn Neurosci Neuroimaging. 2021. Vol. 6, No. 8. P. 802–812. DOI: 10. 1016/j. bpsc. 2020. 08. 008

[11] Kapitsa IG, Ivanova EA, Voronina TA, Seredenin SB. Autism-relevant behavioral traits in inbred strain of BALB/C mice. Russian journal of physiology. 2020;106(3):373–383. (In Russ. ) DOI: 10. 31857/S0869813920020053

[12] Капица И. Г., Иванова Е. А., Воронина Т. А., Серединин С. Б. Особенности поведенческого фенотипа мышей линии BALB/c // Российский физиологический журнал им. И. М. Сеченова. 2020. Т. 106, № 3. С. 373–383. DOI: 10. 31857/S0869813920020053

[13] Semenova AA, Lopatina OL, Salmina AB. Autism models and assessment techniquesfor autistic-like behavior in animals. Zhurnal vysshei nervnoi deyatelnosti imeni I. P. Pavlova. 2020;70(2):147–162. (In Russ. ) DOI: 10. 31857/S0044467720020112

[14] Семёнова А. А., Лопатина О. Л., Салмина А. Б. Модели аутизма и методики оценки аутистически-подобного поведения у животных // Журнал высшей нервной деятельности им. И. П. Павлова. 2020. Т. 70, № 2. С. 147–162. DOI: 10. 31857/S0044467720020112

[15] Karpova IV, Popkovsky NA, Proshin SN, et al. Morphological differences in the commissural connections of the forebrain in white outbred mice and BALB/C mice. Medical academic journal. 2021;21(2):99–105. (In Russ. ) DOI: 10. 17816/MAJ71636

[16] Карпова И. В., Попковский Н. А., Прошин С. Н., и др. Морфологические различия комиссуральных связей переднего мозга у белых беспородных мышей и мышей линии BALB/C // Медицинский академический журнал. 2021. Т. 21, № 2. C. 99–105. DOI: 10. 17816/MAJ71636

[17] Buresh Ya, Bureshova O, Kh’yuston DP. Metodika i osnovnye ehksperimenty po izucheniyu mozga i povedeniya. Moscow: Vysshaya shkola, 1991. 399 p. (In Russ. )

[18] Буреш Я., Бурешова О., Хьюстон Д. П. Методика и основные эксперименты по изучению мозга и поведения. Москва: Высшая школа, 1991. 399 с.

[19] Mikheev VV, Shabanov PD. Farmakologicheskaya asimmetriya mozga. Saint Petersburg: Ehlbi-SPb, 2007. 384 p. (In Russ. )

[20] Михеев В. В., Шабанов П. Д. Фармакологическая асимметрия мозга. Санкт-Петербург: Элби-СПб, 2007. 384 с.

[21] Stahl SM. Stahl’s essential psychopharmacology: neuroscientific basis and practical application. 4th Edition. Cambridge: Cambridge University Press, 2013. 608 p.

[22] Stahl S. M. Stahl’s essential psychopharmacology: neuroscientific basis and practical application. 4th Edition. Cambridge: Cambridge University Press, 2013. 608 p.

RIGHTS & PERMISSIONS

Eco-Vector